Prevail是一家生物技术公司,致力于为神经退行性疾病患者开发潜在的基于疾病改良AAV9的基因疗法。#生物医药下一个十年# #AAV基因治疗#查看全文
消灵通2020-12-15 22:44
$Prevail Therapeutics(PRVL)$ $礼来(LLY)$ 礼来上涨2%,Prevail Therapeutics飙涨83%;礼来宣布以8.8亿美元或每股22.5美元的价格收购Prevail Therapeutics。查看全文
牛唐2020-12-15 21:55
$礼来(LLY)$ Buy $Prevail Therapeutics(PRVL)$ for $22.50/Share in Cash ,一天一个并购,$美国生科ETF-SPDR(XBI)$ 又要嗨了查看全文
华尔街操盘手_2019-06-21 00:15
$Slack Technologies(WORK)$ $Grocery Outlet(GO)$ $Prevail Therapeutics(PRVL)$ 最全ipo上市列表 网页链接查看全文
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005455 Size: 8 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005429 Size: 13 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005432 Size: 14 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005408 Size: 9 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005410 Size: 9 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-005411 Size: 8 KB 网页链接
$Prevail Therapeutics(PRVL)$ 内部交易: 2021-01-22,10% Owner,Tyto Acquisition Corp ,买入,34284789普通股, $22.50
$Prevail Therapeutics(PRVL)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-014807 Act: 33 Size: 18 KB 网页链接
$Prevail Therapeutics(PRVL)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-014812 Act: 33 Size: 18 KB 网页链接
$Prevail Therapeutics(PRVL)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-014799 Act: 33 Size: 19 KB 网页链接